| scholarly article | Q13442814 |
| P50 | author | Sonja Hoeller | Q89986577 |
| P2093 | author name string | Martin Prinz | |
| Johannes Nepp | |||
| Anna Prinz | |||
| Wolfgang Knoetzl | |||
| P2860 | cites work | Reliability of 4 clinical grading systems for corneal staining. | Q50723717 |
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate | Q80754417 | ||
| Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology | Q88086011 | ||
| Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications | Q26796623 | ||
| In situ gelable interpenetrating double network hydrogel formulated from binary components: thiolated chitosan and oxidized dextran | Q34958564 | ||
| Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion | Q36640556 | ||
| Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials | Q37392189 | ||
| TFOS DEWS II Epidemiology Report | Q38652994 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| TFOS DEWS II Introduction. | Q39453315 | ||
| Effect of Topically Administered Chitosan-N-acetylcysteine on Corneal Wound Healing in a Rabbit Model. | Q41038031 | ||
| Effect of different chitosan derivatives on in vitro scratch wound assay: a comparative study | Q42473836 | ||
| Corneal fluorescein staining correlates with visual function in dry eye patients | Q48211343 | ||
| A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome. | Q50702654 | ||
| P921 | main subject | eye disease | Q3041498 |
| P577 | publication date | 2020-03-02 | |
| P1433 | published in | International Ophthalmology | Q15763839 |
| P1476 | title | Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series |
Search more.